$ Value
$0
Shares
143,985
Price
$0
Filed
Mar 9
Insider
Name
Bedrosian Camille L
Title
Chief Medical Officer
CIK
0001326969
Roles
Transaction Details
Transaction Date
2026-03-05
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
143,985
Footnotes
The reported transaction involves the Reporting Person's receipt of a restricted stock unit ("RSU") award. The RSUs shall vest in 4 equal annual installments, with the first installment vesting on March 1, 2027, subject to the Reporting Person's continued service to the Issuer through each such vesting date. | 25% of the shares subject to the option shall vest and become exercisable on March 1, 2027, and the remaining shares shall vest monthly over the remaining 36 months, subject to the Reporting Person's continuous service to the Issuer through each such vesting date.
Filing Info
Bedrosian Camille L's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-05 | AMLX | A | $0 |
| 2026-03-05 | AMLX | A | $0 |
| 2026-03-02 | AMLX | ▼ | $94K |
| 2025-12-01 | AMLX | ▼ | $94K |
| 2025-09-30 | AMLX | ▼ | $176K |
| 2025-06-24 | RYTM | A | $0 |
| 2025-06-24 | RYTM | A | $0 |
| 2025-06-18 | RYTM | M | — |
| 2025-06-18 | RYTM | M | $0 |
| 2025-06-11 | CRNX | A | $0 |
Other Insiders at AMLX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
FRATES JAMES M
Chief Financial Officer
|
— | $167K | 2026-03-05 |
|
Bedrosian Camille L
Chief Medical Officer
|
— | $94K | 2026-03-05 |
|
Klee Justin B.
Co-Chief Executive Officer
|
— | $651K | 2026-03-05 |
|
Cohen Joshua B
Co-Chief Executive Officer
|
— | $652K | 2026-03-05 |
|
Mazzariello Gina
Chief Legal Officer
|
— | $198K | 2026-03-05 |